- Bymaster FP, Calligaro DO, Falcone JF et al. (1996) Radioreceptor binding profile of the atypical antipsydiotic olanzapine. Neuropsychopharmacd 14: 87-96.
- Beasley CM, Tollefson GD, Tran PV (1997) Efficacy of olanzapine: An overview of pivotal clinical trials. J Clin Psychiatry 58 (suppl 10): 7-12.
- Baldwin DS, Montgomery SA (1995) First clinical experience with olanzapine (LY170053) : results of an open label safety and dose-ranging study in patients with schizophrenia. Int Clin Psychopharmacol 10: 239-44.
- Beasley CM, Tollefson GD, Tran PV (1997) Safety of olanzapine.J Clin Psychiatry 58 (suppl 10 ): 13-17.
- Gray R (1998) Olanzapine: efficacy in treating the positive and negative symptoms of schizophrenia. Mental Health Care 1: 193-4.
- Ghaemi N, Goodwin FK (1999) Use of atypical antipsydiotic agents in bipolar and schizoaffective dissorders. Review of the empirical literature. J Clin Psychopharmacd 19: 354-61.
- Berk M, Ichim L, Brook S (1999) Olanzapine compared to lithium in mania: a double blind randomized controlled trial. Int Clin Psychopharmacd 14: 339-43.
- Sipahimalani A, Masand PS (1998) Olanzapine in the treatment of delirium. Psychosomatics 39: 422-30.
- Francis J, Martin D, Kapoor WN (1990) A prospective study of delirium in hospitalized elderly. JAMA 263: 1097-101.
- Khouzam HR, Emery PE, Reaves B (1994) Secondary mania in late life. J Am Geriatric Soc 42: 85-7.
- June LE (1991) Post-operative delirium. Int Psychogeriatrics 3: 325-31
- Weddington WW (1982) The mortality of delirium: An underappreciated problem? Psychosomatics 23: 1232-5.
- Breitbart W, Marotta R, Platt MM et al (1996) A double blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153: 231-7.
- Kane JM (1993) Newer antipsychotic drugs. A review of their pharmacology and therapeutic potential. Drugs 46: 585-93.
- Fish DN (1991) Treatment of delirium in the critically ill patient Clin Pharm 10: 456-66.
- Frye MA, Coudreaut MF, Hakeman SM et al (1995) Continuous droperidol infusion for management of agitated delirium in an intensive care unit Psychosamatics 36: 301-5.
- Kahn M, Green Al (1994) Psychosis, delirium or both? Harvard Rev Psychiatry 2: 34-8.
- Lecompte D, Cookson RF (1999) The economic value of atypical antipsychotics: a comparison of risperidone and olanzapine revisited. Int J Psych Clin Pract 3: 3-9.
- Meltzer HY (1992) Dimensions of outcome with clozapine. Br J Psychiatry 160 (suppl 17): 46-53.
- Casey DE (1997) How antipsychotic drug pharmacology relates to side effects. J Clin Psychiatry, Monograph 15 (2): 30-33.
- Richelson E (1996) Preclinical pharmacology of neuroleptics: Focus on new generation compounds. J Clin Psychiatry 57 (suppl 11): 4-11.
- Moltz DA, Coeytaux RR (1998) Case report· Possibleneuroleptic malignant syndrome associated with olanzapine (Letter). J Clin Psychopharmacd 18: 485-6.
- John V, Rapp M, Pies R (1998) Aggression, agitation, and mania with olanzapine (Letter). Can J Psychiatry 43: 1054.
- Kasper S (1998) Risperidone and olanzapine; optimal dosing for efficacy and tolerability in patients with schizophrenia. Int Clin Psychapharmacol 13: 253-61
- Antonini A, Leeders KL (1993) Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and uC-raclopride.Ann NY Acad Sci 695: 81-5.
- Coryell W, Miller DD, Perry PJ (1998) Haloperidol plasma levels and dose optimization. Am J Psychiatry 155: 48-53.
- Woods S, Ziedonis DM, Sernyak MJ et al (2000) Characteristics of participants and non-participants in medication trials for treatment of schizophrenia Psychiatric Services 51: 79-84.
International Journal of Psychiatry in Clinical Practice
Volume 5, 2001 - Issue 1